The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells
BCR-ABL 抑制剂尼洛替尼影响单核细胞衍生的人类树突状细胞的表型和功能
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-018-2129-9
Daniela Dörfel, Christian J Lechner, Simone Joas, Tanja Funk, Michael Gutknecht, Julia Salih, Julian Geiger, Korbinian N Kropp, Stefanie Maurer, Martin R Müller, Hans-Georg Kopp, Helmut R Salih, Frank Grünebach, Susanne M Rittig
